C07C 279/26
X and y being nitrogen atoms, i.e. biguanides
Official title: X and Y being nitrogen atoms, i.e. biguanides
C07C279/26 (X and y being nitrogen atoms, i.e. biguanides) appears on 153 US grants and 154 published applications in this corpus.
Search patents in C07C- Granted patents
- 153
- Published applications
- 154
- Assignees
- 125
- Inventors
- 422
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 6 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 5 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 1 | 0 |
| 1997 | 5 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 1 |
| 2003 | 2 | 4 |
| 2004 | 2 | 2 |
| 2005 | 2 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 2 |
| 2008 | 1 | 6 |
| 2009 | 1 | 6 |
| 2010 | 1 | 4 |
| 2011 | 4 | 5 |
| 2012 | 3 | 14 |
| 2013 | 3 | 4 |
| 2014 | 4 | 8 |
| 2015 | 11 | 11 |
| 2016 | 5 | 8 |
| 2017 | 7 | 11 |
| 2018 | 8 | 7 |
| 2019 | 11 | 14 |
| 2020 | 10 | 13 |
| 2021 | 4 | 7 |
| 2022 | 7 | 13 |
| 2023 | 4 | 3 |
| 2024 | 6 | 4 |
| 2025 | 4 | 3 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Bis-biguanide compounds, pharmaceutical compositions and uses in managing cancer24 Mar 2026US 12,582,618 B2Emory University
- Nanoparticle composition and method of inhibiting ovarian cancer cell viability6 Jan 2026US 12,515,963 B2
- Compounds with biguanidyl radical and uses thereof16 Sep 2025US 12,415,781 B2Centre National De La Recherche Scientifique
- Metformin complexes with transition metals and P group elements8 Jul 2025US 12,351,592 B2Universidad Santiago De Cali
- Class A GPCR-binding compound modifier15 Apr 2025US 12,275,687 B2Riken
- Improved enzyme-assisted synthesis of chlorhexidine base30 Jul 2026US 2026/0218252 A1Xttrium Laboratories, Inc.
- Bis-Biguanide Compounds, Pharmaceutical Compositions and Uses in Managing Cancer2 Jul 2026US 2026/0183251 A1Emory University
- Nanoparticle composition and method of use and manufacture19 Mar 2026US 2026/0078012 A1
- Compounds with biguanidyl radical and uses thereof8 Jan 2026US 2026/0008748 A1Centre National De La Recherche Scientifique
- Crystalline form of indaziflam, methods for its preparation and use thereof18 Dec 2025US 2025/0382272 A1Adama Agan Ltd.
Most cited
By later US patents
- 1,2-Biguanides80US 3,960,949 ASchering Corporation · 1976
- Antibacterially active hexamethylene-bis-biguanides70US 4,022,834 AA/S Farmaceutisk Industri · 1977
- Metformin glycinate salt for blood glucose control54US 8,703,183 B2Laboratorios Silanes S.A. de C.V. · 2014
- Salts of metformin and method52US 6,031,004 ABristol-Myers Squibb Company · 2000
- Polymeric biocidal agents51US 5,142,010 AH. B. Fuller Licensing & Financing, Inc. · 1992